Vaxess lays out path to the clinic for its silk-derived, drug-dispersing patch

The Cambridge-based biotech has spent the last seven years developing a patch it hopes will disperse everything from vaccines to cancer treatments through roughly 120 microscopic needles made from silk proteins.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news